WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, May 8, 2020 /EINPresswire.com/ -- Cancer affects everyone. Everyone knows someone, either a friend or family member, who has had the disease.

Of the seven most common cancers in men, three of them are urologic, the most common being prostate cancer, followed by bladder and kidney cancer.

Dr. Michael Whalen is a Urologic Oncologist dedicated to the treatment of genitourinary malignancies. Dr. Whalen treats everything from bladder, kidney and prostate cancer to adrenal, testicular and ureteral cancer. He has integrated the growing arsenal of genomic predictive tools and biomarkers into his clinical practice to bring the cutting edge of Precision and Personalized medicine to his patients.

“Despite all of our knowledge, it seems we still have a lot to learn about cancer,” says Dr. Whalen. “I'm a surgical oncologist, I use surgery to treat cancer, but no two tumors are exactly the same, so the path is not always straight forward. There's no silver bullet, of course, but we're now understanding there is more of a genetic component to cancer than we may have fully realized in the past.”

Dr. Whalen is renowned for his expertise in the surgical management of high-risk genitourinary cancer patients and in the use of robotic-assisted surgery with the DaVinci robotic platform.

“Robotic surgery allows certain advantages while harnessing the power of minimally invasive surgery. There's better cosmetic outcome, less pain, faster recovery, usually less blood loss. It allows us to do more precise surgery,” says Dr. Whalen. “Any surgical modality is effective in the hands of a competent surgeon, but the robot has really changed the game. It has really proven to be beneficial. We're always aware of what's going on in the field so that we can offer these new cutting edge things for our patients.”

Alongside his practice, Dr. Whalen serves as Assistant Professor of Urology and Urologic Oncology at the George Washington University School of Medicine and Health Sciences. He is also the Director of the Genitourinary Oncology Multi-Disciplinary Clinic at the GW Cancer Center and serves as GW Site Director for the National Cancer Institute Urologic Oncology Fellowship Program, which is dedicated to training future generations of Urological cancer surgeons.

“I'm a big believer in knowledge is power,” says Dr. Whalen. “There's a lot of fear associated with this kind of diagnosis and fear breeds anxiety and uncertainty. During a consultation of a cancer diagnosis and treatment options, patients probably only retain about 40 percent of what I say. I walk a fine line between being thorough and overwhelming someone with information. But, beyond understanding of the disease process alone, I believe I can provide reassurance that I'm going to work very hard to make them better.”

Close Up Radio will feature Dr. Michael Whalen in an interview with Jim Masters on May 12th at 10am EDT

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook